Trial Profile
A Study of the Effect of RG1662 on Metformin in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs Basmisanil (Primary) ; Metformin
- Indications Down syndrome
- Focus Pharmacokinetics
- Sponsors Roche
- 01 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 11 May 2015 Planned End Date changed from 1 Mar 2015 to 1 May 2015 as reported by ClinicalTrials.gov
- 11 May 2015 Planned primary completion date changed from 1 Mar 2015 to 1 May 2015 as reported by ClinicalTrials.gov